These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6430939)

  • 21. Improved method for the rapid determination of isosorbide dinitrate in human plasma and its application in pharmacokinetic studies.
    Laufen H; Scharpf F; Bartsch G
    J Chromatogr; 1978 Nov; 146(3):457-64. PubMed ID: 721922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].
    Menke G; Schnellhammer R; Rietbrock N
    Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
    Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
    Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasma levels of isosorbide dinitrate and its metabolites during intravenous infusion in surgical patients--effect of preoperative administration of isosorbide dinitrate].
    Murakawa T; Hashimoto Y; Sato T; Takagi H; Kushikata T; Araki I; Kou H; Kimura F; Matsuki A
    Masui; 1993 Feb; 42(2):225-32. PubMed ID: 8437354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of isosorbide dinitrate and glyceryl trinitrate metabolites formed by selected segments of the rabbit gastrointestinal tract.
    Tam GS; MacMillan H; Bennett BM; Marks GS; Brien JF; Nakatsu K
    Can J Physiol Pharmacol; 1988 Feb; 66(2):166-70. PubMed ID: 3130974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saliva concentrations of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrate.
    Taylor IW; Major RM; Chasseaud LF; Taylor T
    Br J Clin Pharmacol; 1984 May; 17(5):585-7. PubMed ID: 6733004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
    Straehl P; Galeazzi RL
    Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of electric foot shock on pharmacokinetics of isosorbide dinitrate orally administered to rats.
    Gomita Y; Furuno K; Araki Y
    Jpn J Pharmacol; 1989 Feb; 49(2):297-9. PubMed ID: 2733266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
    Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
    Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative determination of isosorbide dinitrate and two metabolites in plasma.
    Chin DA; Prue DG; Michelucci J; Kho BT; Warner CR
    J Pharm Sci; 1977 Aug; 66(8):1143-5. PubMed ID: 894502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gas chromatographic-mass spectrometric determination of isosorbide 5-mononitrate in human plasma.
    Lauro-Marty C; Lartigue-Mattei C; Chabard JL; Beyssac E; Aiache JM; Madesclaire M
    J Chromatogr B Biomed Appl; 1995 Jan; 663(1):153-9. PubMed ID: 7704204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of plasma concentrations of isosorbide dinitrate.
    Doyle E; Chasseaud LF; Taylor T
    Biopharm Drug Dispos; 1980; 1(3):141-7. PubMed ID: 7448341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of electric foot shock on pharmacokinetics of isosorbide dinitrate subcutaneously administered to rats.
    Gomita Y; Furuno K; Araki Y
    Jpn J Pharmacol; 1989 Sep; 51(1):132-5. PubMed ID: 2810934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma disposition and hemodynamic effects of a single oral dose of isosorbide dinitrate in human males and females.
    Nakatsu K; Brien JF; Savard G; Toffelmire EB; Abdollah H; Bennett BM; Marks GS
    Biopharm Drug Dispos; 1992 Jul; 13(5):357-67. PubMed ID: 1498268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of plasma concentrations of vasodilators and metabolites by the TEA Analyzer.
    Yu WC; Goff EU
    Biopharm Drug Dispos; 1983; 4(4):311-9. PubMed ID: 6419790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex- and species-related differences in the biotransformation of isosorbide dinitrate by various tissues of the rabbit and rat.
    Tam GS; Marks GS; Brien JF; Nakatsu K
    Can J Physiol Pharmacol; 1987 Jul; 65(7):1478-83. PubMed ID: 3664361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of isosorbide dinitrate and isosorbide-5-mononitrate on prostacyclin (PGI2) and thromboxane A2 (TXA2) generation in rat and human arteries.
    Nakabayashi S; Uyama O; Nagatsuka K; Uehara A; Wanaka A; Yoneda S; Kimura K; Kamata T
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):323-32. PubMed ID: 3887528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability and pharmacokinetics of a new isosorbide dinitrate spray preparation in healthy volunteers.
    Hutt V; Theodor R; Pabst G; Lutz D; Bonn R; Fritschi E
    Arzneimittelforschung; 1993 Aug; 43(8):842-6. PubMed ID: 8216439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
    Schaumann W
    Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemodynamic effects of a transdermal formulation of isosorbide dinitrate and its pharmacokinetics in conscious dogs].
    Kogi K; Tanaka O; Kimura T; Saito T
    Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):279-88. PubMed ID: 7152395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.